Literature DB >> 18528433

Genetic variation in drug transporters in ethnic populations.

C D Cropp1, S W Yee, K M Giacomini.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 18528433      PMCID： PMC2976712          DOI： 10.1038/clpt.2008.98

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  24 in total

1.  Natural variation in human membrane transporter genes reveals evolutionary and functional constraints.

Authors:  Maya K Leabman; Conrad C Huang; Joseph DeYoung; Elaine J Carlson; Travis R Taylor; Melanie de la Cruz; Susan J Johns; Doug Stryke; Michiko Kawamoto; Thomas J Urban; Deanna L Kroetz; Thomas E Ferrin; Andrew G Clark; Neil Risch; Ira Herskowitz; Kathleen M Giacomini
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-28       Impact factor: 11.205

2.  A human transporter protein that mediates the final excretion step for toxic organic cations.

Authors:  Masato Otsuka; Takuya Matsumoto; Riyo Morimoto; Shigeo Arioka; Hiroshi Omote; Yoshinori Moriyama
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-05       Impact factor: 11.205

Review 3.  Pharmacogenomics of organic anion-transporting polypeptides (OATP).

Authors:  Rommel G Tirona; Richard B Kim
Journal:  Adv Drug Deliv Rev       Date:  2002-11-18       Impact factor: 15.470

Review 4.  Apical/basolateral surface expression of drug transporters and its role in vectorial drug transport.

Authors:  Kousei Ito; Hiroshi Suzuki; Toshiharu Horie; Yuichi Sugiyama
Journal:  Pharm Res       Date:  2005-09-22       Impact factor: 4.200

5.  Involvement of uric acid transporter in increased renal clearance of the xanthine oxidase inhibitor oxypurinol induced by a uricosuric agent, benzbromarone.

Authors:  Takashi Iwanaga; Daisuke Kobayashi; Masamichi Hirayama; Tomoji Maeda; Ikumi Tamai
Journal:  Drug Metab Dispos       Date:  2005-08-31       Impact factor: 3.922

Review 6.  Mechanisms of resistance to anticancer drugs: the role of the polymorphic ABC transporters ABCB1 and ABCG2.

Authors:  Erin R Lepper; Kees Nooter; Jaap Verweij; Milin R Acharya; William D Figg; Alex Sparreboom
Journal:  Pharmacogenomics       Date:  2005-03       Impact factor: 2.533

Review 7.  ABC drug transporters: hereditary polymorphisms and pharmacological impact in MDR1, MRP1 and MRP2.

Authors:  R Kerb; S Hoffmeyer; U Brinkmann
Journal:  Pharmacogenomics       Date:  2001-02       Impact factor: 2.533

8.  Molecular identification of a renal urate anion exchanger that regulates blood urate levels.

Authors:  Atsushi Enomoto; Hiroaki Kimura; Arthit Chairoungdua; Yasuhiro Shigeta; Promsuk Jutabha; Seok Ho Cha; Makoto Hosoyamada; Michio Takeda; Takashi Sekine; Takashi Igarashi; Hirotaka Matsuo; Yuichi Kikuchi; Takashi Oda; Kimiyoshi Ichida; Tatsuo Hosoya; Kaoru Shimokata; Toshimitsu Niwa; Yoshikatsu Kanai; Hitoshi Endou
Journal:  Nature       Date:  2002-04-14       Impact factor: 49.962

Review 9.  Pharmacological and physiological functions of the polyspecific organic cation transporters: OCT1, 2, and 3 (SLC22A1-3).

Authors:  Johan W Jonker; Alfred H Schinkel
Journal:  J Pharmacol Exp Ther       Date:  2003-10-23       Impact factor: 4.030

Review 10.  Polymorphism of cytochrome P450 and xenobiotic toxicity.

Authors:  Magnus Ingelman-Sundberg
Journal:  Toxicology       Date:  2002-12-27       Impact factor: 4.221
View more
  11 in total

Review 1.  Oseltamivir in seasonal, avian H5N1 and pandemic 2009 A/H1N1 influenza: pharmacokinetic and pharmacodynamic characteristics.

Authors:  Nicolas Widmer; Pascal Meylan; Anton Ivanyuk; Manel Aouri; Laurent A Decosterd; Thierry Buclin
Journal:  Clin Pharmacokinet       Date:  2010-11       Impact factor: 6.447

Review 2.  Interethnic differences in pharmacokinetics of antibacterials.

Authors:  Danny Tsai; Janattul-Ain Jamal; Joshua S Davis; Jeffrey Lipman; Jason A Roberts
Journal:  Clin Pharmacokinet       Date:  2015-03       Impact factor: 6.447

3.  Central nervous system penetration of antiretroviral drugs: pharmacokinetic, pharmacodynamic and pharmacogenomic considerations.

Authors:  Eric H Decloedt; Bernd Rosenkranz; Gary Maartens; John Joska
Journal:  Clin Pharmacokinet       Date:  2015-06       Impact factor: 6.447

Review 4.  Evaluation of in vivo P-glycoprotein phenotyping probes: a need for validation.

Authors:  Joseph D Ma; Shirley M Tsunoda; Joseph S Bertino; Meghana Trivedi; Keola K Beale; Anne N Nafziger
Journal:  Clin Pharmacokinet       Date:  2010-04       Impact factor: 6.447

Review 5.  Intracellular Pharmacokinetics of Antiretroviral Drugs in HIV-Infected Patients, and their Correlation with Drug Action.

Authors:  Caroline Bazzoli; Vincent Jullien; Clotilde Le Tiec; Elisabeth Rey; France Mentré; Anne-Marie Taburet
Journal:  Clin Pharmacokinet       Date:  2010       Impact factor: 6.447

6.  Functional genetic variation in the basal promoter of the organic cation/carnitine transporters OCTN1 (SLC22A4) and OCTN2 (SLC22A5).

Authors:  Harunobu Tahara; Sook Wah Yee; Thomas J Urban; Stephanie Hesselson; Richard A Castro; Michiko Kawamoto; Doug Stryke; Susan J Johns; Thomas E Ferrin; Pui-Yan Kwok; Kathleen M Giacomini
Journal:  J Pharmacol Exp Ther       Date:  2009-01-13       Impact factor: 4.030

Review 7.  Drug transporters in the human blood-placental barrier.

Authors:  Kirsi Vähäkangas; Päivi Myllynen
Journal:  Br J Pharmacol       Date:  2009-09-25       Impact factor: 8.739

Review 8.  Molecular modeling and ligand docking for solute carrier (SLC) transporters.

Authors:  Avner Schlessinger; Natalia Khuri; Kathleen M Giacomini; Andrej Sali
Journal:  Curr Top Med Chem       Date:  2013       Impact factor: 3.295

9.  Does Ethnic Variability Exist in the Systemic Exposures of OATP1A2 Substrates-Fexofenadine in Taiwanese?

Authors:  Y A Chen; C H Juan; K Y Hsu
Journal:  Indian J Pharm Sci       Date:  2015 Sep-Oct       Impact factor: 0.975

Review 10.  A narrative review of the importance of pharmacokinetics and drug-drug interactions of preventive therapies in migraine management.

Authors:  Shivang Joshi; Stewart J Tepper; Sylvia Lucas; Soeren Rasmussen; Rob Nelson
Journal:  Headache       Date:  2021-06       Impact factor: 5.887
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.